For immediate release |
13 May 2009 |
Futura Medical plc
('Futura' or 'the Company')
Annual Report and Notice of AGM
Futura Medical plc (AIM: FUM), the pharmaceutical group that develops innovative products for consumer healthcare, is pleased to announce that its annual report and accounts for the year ended 31 December 2008 is now available on the Company's website www.futuramedical.co.uk. A printed copy may also be requested by email at annualreport@futuramedical.co.uk
The AGM notice (including Explanatory Notes and Form of Proxy) has now been posted to shareholders. The AGM will be held at 5pm on 10 June 2009.
For any further information please contact:
Futura Medical plc
|
|
James Barder, Chief Executive
|
Tel: +44 (0) 1483 685 670
|
|
|
mail to: james.barder@futuramedical.co.uk
|
|
|
|
Canaccord Adams
|
|
Ryan Gaffney / Adria Da Breo-Richards
|
Tel: +44 (0) 20 7050 6500
|
|
|
For media enquiries please contact:
|
|
|
|
Buchanan Communications
|
|
Mark Court / Rebecca Skye Dietrich / Stasa Filiplic
|
Tel: +44 (0) 20 7466 5000
|
Notes to Editors
Futura Medical plc
Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.
Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.